Eksperimental'naia i klinicheskaia farmakologiia
Eksp Klin Farmakol
· ISSN (print) 0869-2092
· 2 papers in corpus
rct
2013
Two-week-long, prospective, placebo-controlled, single-blind randomized study of the effects of intravenous emoxipin (150 mg daily), reamberin (400 ml daily) and mexidol (300 mg daily) infusion on the dynamics of clinical symptoms of non-co…
rct
2012
Short-term, prospective placebo-controlled simple blind randomized study of the effects of 3-oxypyridine and succinic acid derivatives (emoxipin, reamberin, mexidol) on the affective status of females with recrudescence of the inflammatory …